-
Information-Publications
-
Pathogenicity and functional analysis of CFAP410 mutations causing cone-rod dystrophy with macular staphylomaDetails
-
A novel and secure pseudovirus reporter system based assay for neutralizing and enhancing antibody assay against Marburg virusDetails
-
RIP3-mediated necroptosis is regulated by inter-filament assembly of RIP homotypic interaction motifDetails
-
ZLN005 alleviates in vivo and in vitro renal fibrosis via PGC-1α-mediated mitochondrial homeostasisDetails
-
FBXL4 mutations cause excessive mitophagy via BNIP3/BNIP3L accumulation leading to mitochondrial DNA depletion syndromeDetails
-
Discovery and characterization of SARS-CoV-2 reactive and neutralizing antibodies from humanized CAMouseHG mice through rapid hybridoma screening …Details
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands